We provide specialist services to the pharmaceutical industry
We are a flexible organisation, with resources and infrastructure to handle projects of all sizes.
Founded in 2007, S-cubed provides clients with a wide range of tailored services, from in-sourcing solutions, individual ad-hoc advice and consultancy, to delivering large projects.
Our team of over 60 carefully selected and highly experienced staff has extensive expertise in supporting projects ranging from pre-clinical and clinical development, pharmaceutical licensing in the EU and US, medical technology research and other healthcare management activities.
Recognising that one size doesn’t fit all, we customise our services to meet client needs. We focus on providing a high level of expertise and cost-effective solutions.
We have long lasting relationships with our clients. Our vision is that every client will experience complete confidence in the knowledge, abilities and reliability of our staff, and will see clear benefits and results from our involvement in their projects.
Based in Denmark and the UK, we work with clients from around the globe.
Managing Director & SAS Solution Specialist
Scott started working as a SAS Programmer 1990 and, before founding S-cubed ApS in 2007, he worked in various industries, including the pharmaceutical, finance, transport and public sectors. He has exceptional knowledge of SAS and specialises in web-based application development. Scott has in depth knowledge in application development, data conversion, reporting and submission projects, and has worked extensively on projects involving the implementation and utilisation of CDISC standards.
Partner and Data Standardisation & Implementation Specialist
Niels Both has worked with clinical data handling and reporting since 1997, and has specialised in implementation of standard data models and standard reporting tools. Since 2004 Niels’ focus has been on the use of CDISC standards for FDA submissions, data warehousing and standardisation of dataflow processes from protocol to submission. Niels is an active member of the European CDISC Co-ordination Committee – E3C, and as part of this committee is working on several CDISC models, including SDTM, ADaM and CDASH. Niels joined S-cubed ApS in 2008.
Managing Director, S-cubed Ltd
Prior to founding S-cubed Ltd with Scott in 2008, Mark had worked in the pharmaceutical industry for 10 years, most recently as a Principal Consultant with PA Consulting Group’s Life Sciences and Healthcare Practice, based in London. During his time as a consultant, Mark has worked with a wide variety of groups including pharmaceutical, biotechnology and investment companies. Prior to entering consultancy, Mark spent 6 years working in the drug development industry as a Clinical Project Manager.
Director of Qlik Development
Working with pharmaceutical data since 1993, Jack specialises in SAS programming, application development and implementation of reporting tools. Jack has considerable experience of working with clinical as well as pharmacovigilance data, and has had leading roles for two eClinical projects, with focus on harvesting the reporting benefits of standards with advanced statistical reporting tools and QlikView. Before joining S-cubed in 2010, Jack was responsible for QlikView Business Intelligence within a large pharmaceutical company, including exploring new business opportunities for the future use of Business Intelligence.
Partner and Director of A3
Dave Iberson-Hurst joined S-cubed in 2019, as Partner and Director of A3 to develop the ground breaking A3 Suite to support the implementation of CDISC Standards. He founded Assero in 2003 to provide consultancy services to industry and develop products and solutions to bring global standards adoption closer to reality. Over the past 15 years, Dave has been instrumental in the development of industry standards for CDISC and has been regularly required to advise both the industry and its regulators on some of the challenges faced when implementing standards. In recent years, he has become a thought leader on the management of metadata within pharmaceutical companies to deliver one source of industry metadata that can be used for multiple purposes. Dave’s vision and ability to communicate the needs of a company to all those involved in the clinical research process has ensured that he is regularly asked to present at global industry events and contribute to a variety of articles.
Adam de Neergard
Partner and Director of Business Development, Software and Services
Adam brings 16 years’ experience with Sales, Sales Leadership and Business Development working in international IT companies like IBM, NNIT, SAS Institute and smaller startups. His primary focus throughout his career has been on building relationships with global Life Sciences organizations and helping digitalizing the industry.
Director of Regulatory Affairs
Stephen joined S-cubed Ltd in early 2009, bringing over ten years’ regulatory affairs experience, most recently as a Director in the Regulatory Affairs group at Constella Group (formerly Origin Pharmaceutical Services). Stephen has provided regulatory support to a number of pharmaceutical and biotechnology companies and has worked with most European regulatory agencies and the US FDA. He has a proven track-record of successfully supporting products through development to registration and subsequent license maintenance. Stephen holds a PhD in Chemistry.
Director of Regulatory Affairs
Upon joining S-cubed Ltd in November 2011, Nicola brought strong leadership and comprehensive registration and regulatory expertise to the regulatory affairs team, acquired through more than eighteen years of experience within the pharmaceutical industry. Nicola provides a strong insight into the differing commercial pressures of product development, gained from working with a wide variety of organisations, ranging from large multinational organisations to small generics companies. Nicola holds an MSc in Biochemical Engineering.
Managing Director & Consultant Statistician
Prior to starting S-cubed Biometrics Ltd in 2011, Mark was Vice President, Data Sciences at SRA Global Clinical Development, where he successfully formed, grew and led the global Biometrics department. Mark has over 23 years’ experience in conducting, managing and leading statistics, programming and data management functions within small and large pharmaceutical and biotech companies, including positions at Pfizer and British Biotech. Mark is a chartered statistician with expertise in statistical consultancy, biometrics project management, statistical programming, drug development and commercial business strategy.